Bilaxten 20 mg
Bilaxten 20 mg is a medicine authorised by Swissmedic under authorisation number 61446. The authorisation holder is A. Menarini GmbH. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 31 October 2011 and the authorisation is valid without a time limit. ATC code R06AX29 places the medicine in the group Antihistamines for systemic use.
| Authorisation number | 61446 |
|---|---|
| Name | Bilaxten 20 mg |
| Full name | Bilaxten 20 mg, Tabletten |
| Authorisation holder | A. Menarini GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | R06AX29 |
| First authorisation | 31 October 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Bilaxten 20 mg, Tabletten | D | 31 October 2011 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 6 | 10 | Tablette(n) | R06AX29 | 07.13.1. | D |
| 8 | 30 | Tablette(n) | R06AX29 | 07.13.1. | D |
| 10 | 50 | Tablette(n) | R06AX29 | 07.13.1. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Bilaxten 20 mg authorised in Switzerland?
Yes. Bilaxten 20 mg is authorised by Swissmedic under authorisation number 61446, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Bilaxten 20 mg have?
Bilaxten 20 mg is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Bilaxten 20 mg?
The authorisation holder is A. Menarini GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.